ciprofloxacin
Ciprofloxacin Tablets 250 mg, 500 mg and 750 mg
Approved
Approval ID
ab62a277-750d-4380-b2bd-f9700eebb128
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 24, 2011
Manufacturers
FDA
RedPharm Drug Inc.
DUNS: 008039641
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ciprofloxacin
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code67296-0620
Application NumberANDA076639
Product Classification
M
Marketing Category
C73584
G
Generic Name
ciprofloxacin
Product Specifications
Route of AdministrationORAL
Effective DateJune 24, 2011
FDA Product Classification
INGREDIENTS (9)
CROSPOVIDONEInactive
Code: 68401960MK
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POLYETHYLENE GLYCOLInactive
Code: 3WJQ0SDW1A
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ciprofloxacin hydrochlorideActive
Quantity: 250 mg in 1 1
Code: 4BA73M5E37
Classification: ACTIM